Optimizing Substrate Dosing for Bioluminescence Imaging

This technical note focuses on optimizing substrate dosing for bioluminescence imaging (BLI) to ensure reliable and consistent results in biological monitoring. It outlines the critical role of luciferase substrate, specifically D-luciferin, in achieving reproducible signal intensities. Variability in dosing can lead to inconsistent data interpretation, making standardization essential. The document details best practices for substrate administration, including dosing based on body weight, preparing fresh solutions, and using standardized routes of administration such as intraperitoneal, intravenous, and subcutaneous methods. It also emphasizes the importance of monitoring signal dynamics and utilizing software features to analyze signal curves. Additionally, troubleshooting tips are provided for addressing variability, such as ensuring solution homogeneity and evaluating injection techniques. The conclusion reiterates the significance of optimizing substrate dosing to enhance the quality of BLI data, ultimately improving the reliability of biological experiments.